no code implementations • 12 Aug 2021 • Raphael Ronge, Kwangsik Nho, Christian Wachinger, Sebastian Pölsterl
The current state-of-the-art deep neural networks (DNNs) for Alzheimer's Disease diagnosis use different biomarker combinations to classify patients, but do not allow extracting knowledge about the interactions of biomarkers.
